Legal Representation
Attorney
Daniel M. Cislo, Esq.
USPTO Deadlines
Next Deadline
979 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20221004)
Due Date
October 04, 2028
Grace Period Ends
April 04, 2029
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
20 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Oct 4, 2022 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Oct 4, 2022 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Aug 31, 2022 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | Loading... |
| Aug 30, 2022 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | Loading... |
| Jun 27, 2022 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
| Jun 7, 2022 | IUAF | S | USE AMENDMENT FILED | Loading... |
| Jun 27, 2022 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Jun 7, 2022 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| Dec 7, 2021 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Oct 12, 2021 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Oct 12, 2021 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Sep 22, 2021 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Sep 7, 2021 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Sep 7, 2021 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Sep 7, 2021 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Sep 7, 2021 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Sep 7, 2021 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Sep 1, 2021 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| May 6, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Feb 5, 2021 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
pharmaceutical preparations for the treatment of COVID 19, Corona viruses, Influenza, Autism, Alzheimer's, Parkinson's Disease, Multiple Sclerosis, Epstein-Barr Virus
First Use Anywhere:
Apr 1, 2019
First Use in Commerce:
Apr 1, 2019
Additional Information
Pseudo Mark
IMPRINT MICRO BIOME
Classification
International Classes
005
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"MICROBIOME"